These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3543939)

  • 1. Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys.
    Pollack S; Rossan RN; Davidson DE; Escajadillo A
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):162-4. PubMed ID: 3543939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine.
    Raventos-Suarez C; Pollack S; Nagel RL
    Am J Trop Med Hyg; 1982 Sep; 31(5):919-22. PubMed ID: 6751113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.
    Peto TE; Thompson JL
    Br J Haematol; 1986 Jun; 63(2):273-80. PubMed ID: 3521714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of night monkeys (Aotus) in research on malaria chemotherapy].
    Rossan RN; Escajadillo A
    Rev Med Panama; 1984 Sep; 9(3):222-5. PubMed ID: 6387820
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    Stahel E; Mazier D; Guillouzo A; Miltgen F; Landau I; Mellouk S; Beaudoin RL; Langlois P; Gentilini M
    Am J Trop Med Hyg; 1988 Sep; 39(3):236-40. PubMed ID: 3052118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelation as a chemotherapeutic strategy for falciparum malaria.
    Gordeuk VR; Thuma PE; Brittenham GM; Biemba G; Zulu S; Simwanza G; Kalense P; M'Hango A; Parry D; Poltera AA
    Am J Trop Med Hyg; 1993 Feb; 48(2):193-7. PubMed ID: 8447522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
    Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
    Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
    Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
    J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sequential infection with Plasmodium vivax and P. falciparum in the Aotus trivirgatus monkey.
    Collins WE; Warren M; Skinner JC; Richardson BB; Kearse TS
    J Parasitol; 1979 Aug; 65(4):605-8. PubMed ID: 117086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of the growth of Plasmodium falciparum by Aotus serum.
    Campbell GH; Mrema JE; O'Leary TR; Jost RC; Rieckmann KH
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):219-25. PubMed ID: 120771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
    Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
    Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria.
    Traore O; Carnevale P; Kaptue-Noche L; M'Bede J; Desfontaine M; Elion J; Labie D; Nagel RL
    Am J Hematol; 1991 Jul; 37(3):206-8. PubMed ID: 1858775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.
    Bitonti AJ; Sjoerdsma A; McCann PP; Kyle DE; Oduola AM; Rossan RN; Milhous WK; Davidson DE
    Science; 1988 Dec; 242(4883):1301-3. PubMed ID: 3057629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of the Indochina I/CDC strain of Plasmodium falciparum to the squirrel monkey (Saimiri sciureus).
    Campbell CC; Collins WE; Milhous WK; Roberts JM; Armstead A
    Am J Trop Med Hyg; 1986 May; 35(3):472-5. PubMed ID: 3518503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro.
    Whitehead S; Peto TE
    Blood; 1990 Sep; 76(6):1250-5. PubMed ID: 2205310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. I. Development in Aotus lemurinus griseimembra monkeys.
    Collins WE; Galland GG; Sullivan JS; Morris CL; Richardson BB; Roberts JM
    Am J Trop Med Hyg; 1996 Apr; 54(4):372-9. PubMed ID: 8615450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vinckei: suppression of mouse infections with desferrioxamine B.
    Fritsch G; Treumer J; Spira DT; Jung A
    Exp Parasitol; 1985 Oct; 60(2):171-4. PubMed ID: 4029347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of increased quinine resistance in Plasmodium falciparum in Aotus monkeys.
    Glew RH; Collins WE; Miller LH
    Am J Trop Med Hyg; 1978 Jan; 27(1 Pt 1):9-13. PubMed ID: 415628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine.
    Oduola AM; Sowunmi A; Milhous WK; Brewer TG; Kyle DE; Gerena L; Rossan RN; Salako LA; Schuster BG
    Am J Trop Med Hyg; 1998 May; 58(5):625-9. PubMed ID: 9598452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of three strains of Plasmodium falciparum isolated by the culture method of Trager and Jensen.
    Chin W; Collins WE
    Am J Trop Med Hyg; 1980 Nov; 29(6):1143-6. PubMed ID: 7004215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.